Medanta – The Medicity has intensified its outreach in the Northeast with a renewed focus on kidney transplant awareness, post-operative care and patient support services, amid rising cases of chronic kidney disease linked to diabetes and hypertension.
In a statement issued on April 28, the Gurugram-based hospital, ranked India’s best hospital by Newsweek in 2026, said kidney transplantation continues to be the preferred treatment option for patients suffering from end-stage renal disease. The hospital highlighted its multidisciplinary transplant programme supported by advanced medical technologies, including robotic surgical systems, aimed at improving patient outcomes and safety.
Dr. Manish Jain, Senior Director, Nephrology at Medanta Gurugram, said long-term care remains critical for transplant success. “A transplant is not a one-time event but a long-term commitment. Patients require regular follow-ups and continued medications,” he said. He added that transplant patients must maintain hygiene and follow strict medication routines to reduce infection risks caused by immunosuppressant drugs.
India sees nearly two lakh patients requiring kidney transplants annually, with most organs donated by living relatives, while deceased donor transplants are gradually increasing due to growing awareness around organ donation.
In Guwahati, healthcare demand for specialised nephrology consultations and transplant-related services is witnessing steady growth as awareness about kidney disease rises across Assam and the Northeast. Hospitals and healthcare providers in Guwahati are increasingly focusing on advanced treatment access, multilingual patient assistance and specialist outreach programmes to cater to patients travelling from neighbouring states for tertiary healthcare services.
